BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will become effective at 5:00 p.m. Eastern Time on February 7, 2025, with the company’s common stock expected to begin trading on a split-adjusted basis at the opening of the market on Monday, February 10, 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTAI:
- BioXcel Therapeutics provides clinical, business update
- BioXcel Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
- Biotech Alert: Searches spiking for these stocks today
- Bioxcel Therapeutics Appoints Dr. Rajiv Patni to Board
- BioXcel Therapeutics files to sell 5.1M shares of common stock for holders